Inhibition of TGF-beta 1 by eNOS gene transfer provides cardiac protection after myocardial infarction

被引:4
作者
Qin, Wei [1 ]
Chen, Xin [1 ]
Liu, Peisheng [1 ]
机构
[1] Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiothorac Surg, Nanjing 210006, Jiangsu, Peoples R China
关键词
endothelial nitric oxide synthase gene; myocardial infarction; cardiac function; cardiomyocyte apoptosis; collagen deposition; transforming growth factor-beta(1);
D O I
10.1016/S1674-8301(10)60023-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: Endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) have been implicated in protection against myocardial ischemia injury. This study was designed to explore a new method of therapy for myocardial injury by eNOS gene transfection. Methods: A rat model of myocardial infarction (MI) was established by left anterior descending (LAD) coronary artery ligation. eNOS gene in an adenovirus vector was delivered locally into the rat heart and hemodynamic parameters were examined after 3 weeks, Matrix metalloproteinase-2 and 9 (MMP-2, MMP-9) mRNA were measured by reverse transcription polymerase chain reaction (RT-PCR), and the protein levels of eNOS, caspase-3, and transforming grouth factor beta(1) (TGF-beta(1)) were determined by western blot assay. Results: eNOS gene transfer significantly reduced cardiomyocyte apoptosis and improved cardiac function. In addition, eNOS significantly reduced the mRNA levels of MMP-2 and MMP-9. In the eNOS gene transfected group, the activation of caspase-3 and TGF-beta(1) were decreased. However, the protection was reversed by administration of the NOS inhibitor, N(omega)-nitro-l-arginine methyl ester (L-NAME). Conclusion: These results demonstrate that the eNOS provides cardiac protection after myocardial infarction injury through inhibition of cardiac apoptosis and collagen deposition, and suppression of TGF-beta(1).
引用
收藏
页码:145 / 152
页数:8
相关论文
共 31 条
[1]  
Pfeffer M.A., Left ventricular remodeling after acute myocardial infarction, Annu Rev Med, 46, pp. 455-466, (1995)
[2]  
Sutton M.G., Sharpe N., Left ventricular remodeling after myocardial infarction: pathophysiology and therapy, Circulation, 101, pp. 2981-2988, (2000)
[3]  
Prabhu S.D., Nitric oxide protects against pathological ventricular remodeling: reconsideration of the role of NO in the failing heart, Circ Res, 94, pp. 1155-1157, (2004)
[4]  
Brutsaert D.L., Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity, Physiol Rev, 83, pp. 59-115, (2003)
[5]  
Feng Q., Song W., Lu X., Hamilton J.A., Lei M., Peng T., Et al., Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase, Circulation, 106, pp. 873-879, (2002)
[6]  
Scherrer-Crosbie M., Ullrich R., Bloch K.D., Nakajima H., Nasseri B., Aretz H.T., Et al., Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice, Circulation, 104, pp. 1286-1291, (2001)
[7]  
Jones S.P., Greer J.J., van Haperen R., Duncker D.J., de Crom R., Lefer D.J., Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice, Proc Natl Acad Sci USA, 100, pp. 4891-4896, (2003)
[8]  
Fraccarollo D., Widder J.D., Galuppo P., Thum T., Tsikas D., Hoffmann M., Et al., Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction, Circulation, 118, pp. 818-827, (2008)
[9]  
Chen L.L., Yin H., Huang J., Inhibition of TGF-β<sub>1</sub> signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis, Cardiovasc Pathol, 16, pp. 221-230, (2007)
[10]  
Ikeuchi M., Tsutsui H., Shiomi T., Matsusaka H., Matsushima S., Wen J., Et al., Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction, Cardiovasc Res, 64, pp. 526-535, (2004)